Combination Therapy with KRAS and P38 alpha siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line


Kamran S., Seyedrezazadeh E., Shanehbandi D., Asadi M., Zafari V., Shekari N., ...More

JOURNAL OF GASTROINTESTINAL CANCER, 2021 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2021
  • Doi Number: 10.1007/s12029-021-00667-1
  • Title of Journal : JOURNAL OF GASTROINTESTINAL CANCER
  • Keywords: Colorectal cancer, KRAS, P38, siRNA, MUTATION STATUS, P38, INHIBITION, KNOCKDOWN, PROGNOSIS

Abstract

Purpose Colorectal cancer (CRC) is one of the most prevalence malignancies in a different society with a high rate of death. The KRAS and p38 alpha axes have critical roles in the development, migration, and growth of numerous tumors, such as colorectal malignancy. KRAS mutation acts as an oncogene in various cancers and is correlated with the poor prognosis in colorectal tumors. Also, p38 alpha plays different roles and exhibits tissue-dependent activity. In some tissues act as an oncogene while in others act as a tumor suppressor. In this research, we try to understand the effect of the P38 alpha and KRAS genes suppression by specific siRNAs on the SW480 cell line progression.